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http://www.parasitesandvectors.com/content/7/1/507RESEARCH Open AccessLymphatic filariasis control in Tanga Region,
Tanzania: status after eight rounds of mass drug
administration
Paul E Simonsen1*, Yahya A Derua2, Stephen M Magesa3, Erling M Pedersen1, Anna-Sofie Stensgaard1,4,
Mwelecele N Malecela5 and William N Kisinza2Abstract
Background: Lymphatic filariasis (LF) control started in Tanga Region of Tanzania in 2004, with annual ivermectin/
albendazole mass drug administration (MDA). Since then, the current project has monitored the effect in
communities and schools in rural areas of Tanga District. In 2013, after 8 rounds of MDA, spot check surveys were
added in the other 7 districts of Tanga Region, to assess the regional LF status.
Methods: LF vector and transmission surveillance, and human cross sectional surveys in communities and schools,
continued in Tanga District as previously reported. In each of the other 7 districts, 2–3 spot check sites were
selected and about 200 schoolchildren were examined for circulating filarial antigens (CFA). At 1–2 of the sites in
each district, additional about 200 community volunteers were examined for CFA and chronic LF disease, and the
CFA positives were re-examined for microfilariae (mf).
Results: The downward trend in LF transmission and human infection previously reported for Tanga District
continued, with prevalences after MDA 8 reaching 15.5% and 3.5% for CFA and mf in communities (decrease by
75.5% and 89.6% from baseline) and 2.3% for CFA in schoolchildren (decrease by 90.9% from baseline). Surprisingly,
the prevalence of chronic LF morbidity after MDA 8 was less than half of baseline records. No infective vector
mosquitoes were detected after MDA 7. Spot checks in the other districts after MDA 8 showed relatively high LF
burdens in the coastal districts. LF burdens gradually decreased when moving to districts further inland and with
higher altitudes.
Conclusion: LF was still widespread in many parts of Tanga Region after MDA 8, in particular in the coastal areas.
This calls for intensified control, which should include increased MDA treatment coverage, strengthening of bed net
usage, and more male focus in LF health information dissemination. The low LF burdens observed in some inland
districts suggest that MDA in these could be stepped down to provide more resources for upscale of control in the
coastal areas. Monitoring should continue to guide the programme to ensure that the current major achievements
will ultimately lead to successful LF elimination.
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Human lymphatic filariasis (LF) is a disfiguring and
disabling mosquito-borne parasitic disease [1]. It is a
major health problem in many warm climate countries
and one of the most prevalent of the so-called Neglected
Tropical Diseases (NTDs). The causative filarial parasites
are transmitted to humans when female mosquito vectors
carrying infective larvae land on the human skin to take a
blood meal. The larvae penetrate the skin and migrate to
the lymphatic vessels where they develop into adult male
and female worms over a period of several months. The
mature fertilized female worms produce large numbers of
tiny larvae called microfilariae (mf) which circulate in the
blood. The mf are ingested by new mosquito vectors when
taking a blood meal and develop into new infective larvae
in the vectors in about 10–14 days. Clinical LF disease
(e.g. acute filarial fever, lymphedema, elephantiasis,
hydrocele) primarily results from damage caused by
the adult worms in the lymphatic vessels. The disease
manifestations can be a cause of considerable incapacity
to the affected individuals, and LF has been recognized as
one of the leading causes of long-term disability in the
world [2].
The World Health Organization launched a Global
Programme to Eliminate Lymphatic Filariasis (GPELF)
in 2000 with the major goal to eliminate LF as a public
health problem [3,4]. GPELF provides guidance and sup-
port to national LF control programmes, and the principal
intervention measure currently recommended is annual
mass drug administration (MDA) with a two-drug
combination to LF endemic communities. In most
countries a combination of diethylcarbamazine (DEC)
and albendazole is used, but due to the risk of serious
adverse reactions in individuals infected with Onchocerca
volvulus, the combination of ivermectin and albendazole is
used in African countries which are co-endemic for these
infections [3,4]. The drugs are mainly microfilaricidal and
the main purpose of the MDA is to kill circulating mf
and thereby to reduce transmission. By preventing
new infections, this strategy should eventually lead to
elimination of LF infection in the population [4,5].
In Africa, where all LF is caused by the filarial nematode
Wuchereria bancrofti, estimates indicate that more than 45
million people are affected [6]. Tanzania ranks as the third
African country in terms of highest LF burden, with over
34 million people living in endemic areas, and more than 6
million infected [7]. Particularly high prevalences have been
reported from the coastal zone along the Indian Ocean
[8-13]. As one of the first countries in Africa, Tanzania
launched a National Lymphatic Filariasis Elimination
Programme (NLFEP) in 2000, and the first MDA was
implemented in endemic areas of Coast Region near
Dar es Salaam in the same year. Since then, the NLFEP
has year by year expanded its geographical coverage, byapplying annual MDA with a combination of ivermec-
tin (150–200 μg/kg body weight) and albendazole
(400 mg/person) to individuals aged ≥5 years in LF
endemic districts. In principle, the community-directed
intervention approach [14] is used for delivering the
drugs, although sometimes a more top-down delivery
mechanism is applied [15]. Since 2009, the NLFEP has
been integrated with the Neglected Tropical Diseases
Control Programme, whereby the MDA for LF control is
coordinated with MDA programmes for other NTDs
prevailing in the same districts.
During 2004–2011 the present study monitored the
effect of the NLFEP MDA activities on LF transmission
and human infection in communities and primary schools
in rural areas of Tanga District [16-18]. It was seen that
the level of transmission and human infection initially
decreased considerably, but also that the effect leveled
off and became less pronounced in subsequent years.
Transmission was still ongoing after 6 MDAs although at a
much reduced level. For logistical reasons, most monitoring
activities were suspended in 2012, with exception of two
months of vector and transmission surveillance. However,
in 2013, the surveys for infection and disease were resumed
in the same communities and schools as previously. In
addition it was decided to add spot check surveys in the
other 7 districts of Tanga Region covered by the LF control
programme, to assess the overall regional LF status after
8 rounds of MDA.
Methods
Study area
All study sites were located in rural areas of Tanga
Region (approx. 2,045,000 inhabitants in 2012) in
north-eastern Tanzania. The region has 8 districts -
Handeni, Kilindi, Korogwe, Lushoto, Mkinga, Muheza,
Pangani and Tanga – of which the latter includes the
regional capital of Tanga City (approx. 270,000 inhabitants).
From the coastal zone along the Indian Ocean the land
gradually rises to a plateau in the hinterland with an
altitude of about 500 meters. From this plateau, the
Nguu mountains (in the western part of Kilindi District),
and the Usambara mountains (in parts of Muheza,
Lushoto and Korogwe districts) further rise to altitudes of
about 1500 meters and >2000 meters, respectively. The
region has two rainy seasons in the year, the long rains
from March to June and the less intensive short rains from
November to December. A map indicating the location of
the study sites in Tanga District is given in [18].
LF control activities in Tanga Region
In 2004, all districts of Tanga Region were enrolled in
the NLFEP and received the first MDA with ivermectin
and albendazole. Following integration of the NLFEP with
the Neglected Tropical Diseases Control Programme in
Simonsen et al. Parasites & Vectors 2014, 7:507 Page 3 of 19
http://www.parasitesandvectors.com/content/7/1/5072009, the MDAs for LF control basically continued as
before, but activities were coordinated with school
based praziquantel treatment for schistosomiasis and
community based treatment with azithromycin for
trachoma (the latter two treatments given two weeks
after the MDA for LF control). The 8 MDAs for LF
control administered during the period covered in the
present study were given in October 2004, February 2006,
May 2007, February 2009, November 2009, December
2010, December 2011 and February 2013 (Figure 1), and
thus had time intervals of 16, 15, 21, 9, 13, 12 and
14 months. Before start of LF control in Tanga Region,
three MDAs with ivermectin for control of onchocerciasis
had been implemented in highland areas of Muheza,
Lushoto and Korogwe districts (in 2001, 2002 and 2003).
Design of community study in Tanga District
Vector and transmission surveillance started in all
four administrative sections (hamlets) of Kirare village
(located about 20 km to the south of Tanga City) in
beginning of November 2003, i.e. about one year before
the first MDA, and continued uninterrupted until the end
of December 2011. The surveillance was resumed for a
two-month period in 2012 (June/July) and 2013
(May/June) towards the end of the long rainy season
(when highest vector density had been noted during
previous years) by using same catching houses and
methods.
A pre-MDA cross-sectional survey of the human
population in all four hamlets of Kirare was carried out
in September 2004 (survey 1), immediately prior to the
first MDA (Figure 1). All individuals aged ≥1 year were
examined for microfilariae (mf) and chronic clinical
manifestations of LF, and volunteers from mosquito
collection houses had venous blood samples collected and
examined for circulating filarial antigen (CFA) by ELISA.
Subsequent similar surveys were carried out in Kirare in
January 2006, January 2007, October 2007, October 2008
and October 2009 (surveys 2–6; Figure 1). In the following
three surveys (7 in November 2010, 8 in November 2011
and 9 in September 2013; Figure 1) some changes were
made. First, only two of the four hamlets comprisingFigure 1 Timing of MDA and survey activities in rural study commun
vertical stippled lines = MDA; Red circles = community surveys; Blue arrowsKirare village (Mtambuuni and Mashine) were included.
As substitutes, and in order to cover a larger geographical
area, one hamlet from each of two other villages in Tanga
District (Mabavu in Kiomoni village about 5 km
north-west of Tanga city, and Majengo in Kisimatui
village about 17 km south-west of Tanga city) were
included. Second, all individuals were first screened
for CFA with rapid ICT card tests during the day,
and only those positive for CFA were screened for mf at
night (no venous blood samples taken). The examination
methods described in the following refer to those used in
survey 7–9, whereas methods used in earlier surveys have
been described previously [16,18].
Design of school study in Tanga District
The new Standard 1 pupils (most being 6–7 years of
age) entering 10 rural primary schools each year were
examined for CFA (Figure 1), as previously described
[17,18]. Briefly, with assistance of the teachers, and by
following the school registers, the pupils were screened
for CFA by use of rapid ICT card tests. The schools were
in four clusters located south-west (Kirare, Mapojoni and
Marungu; no. 1–3), north-west (Kiomoni and Mafuriko;
no. 4–5), close west (Maweni and Kange; no. 6–7) and
more distant west (Pongwe, Kigandini and Ziwani; no.
8–10) of Tanga city. The distance of the schools to
the centre of Tanga city ranged from 5 to 24 km.
Design of spot check surveys in other districts of Tanga
Region
In each of the other 7 districts of Tanga Region, 2–3
villages were purposively selected for spot checks which
were carried out in October/November 2013. Sites were
selected to spatially adequately cover the region and in
areas where the environment appeared to be supportive
to transmission of LF. At each site, approx. 200 pupils
from the local primary school were screened for CFA
with rapid test cards, by following the school registers
and with the assistance of the teachers. Screening started
with pupils in Standard 1, and if these were not enough
it continued with those in Standard 2, 3, etc., until
approx. 200 were reached. At 1–2 of the sites in eachities and schools in Tanga District between 2004 and 2013. Black
= school surveys. Figures above symbols = activity number.
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were requested to come for CFA screening with rapid
test cards, and those ≥15 years were clinically examined
for chronic signs of LF. CFA positive community
members moreover had a finger-prick blood sample
examined for mf in the evening.
Ethical considerations
Meetings were held regularly with the study communities in
Tanga District, and prior to community spot checks in other
districts, to inform the inhabitants about study contents
and to obtain their cooperation. Before any examination,
individuals were asked if the purpose and consequences as
explained during the meetings had been understood, ques-
tions for clarifications were answered, and written consent
to participate was obtained (from adults, and from
parents/guardians of individuals less than 18 years old).
Prior to each years’ school surveys in Tanga District,
meetings were held with the head teacher, the relevant
teachers and the parents committee for the individual
schools, to inform about the contents of the study. The
members of the parents committee provided written
informed consent, on behalf of the children and their
parents. A similar procedure was followed during the
school spot checks in the other districts. Children
who refused to participate in the examinations were
not included.
Individuals were informed about their mf or CFA status
after the surveys, and those found positive were particu-
larly encouraged to participate and take the drugs during
the next MDA. Ethical and research clearance to the study
was provided by the Medical Research Coordinating
Committee of the National Institute for Medical Research
in Tanzania.
Examinations for LF infection and disease
Schoolchildren and community members were examined
for CFA status by use of rapid immunochromatographic
test cards (ICT cards, Binax NOW Filariasis, Inverness
Medical Innovations Inc., USA), by following the manu-
facturers’ instructions. Briefly, one hundred microliters
of finger prick blood were applied to the sample pad on
the test card, and the result was read after 10 minutes as
either positive or negative.
Blood was examined for mf by using the counting
chamber technique [19]. From each individual, 100 μl of
finger prick blood was collected into a heparinized capillary
tube after 21:00 hours (due to the nocturnal mf periodicity
in the study area) and transferred into a microtube with
900 μl of 3% acetic acid. Later in the laboratory the speci-
mens were transferred to a counting chamber and examined
for mf under a compound microscope. The specimens were
examined blinded by two different technicians, and the
mean count was used as the mf intensity.During community surveys all study individuals were ex-
amined for chronic manifestations of LF by a clinical officer.
Manifestations were graded as described previously [10],
but in this presentation lymphoedema/elephantiasis ≥ grade
I (loss of contour, pitting oedema) and hydrocele ≥ stage II
(true hydrocele ≥6 cm, with fluid accumulation) are
reported as elephantiasis and hydrocele, respectively.
Vector and transmission surveillance
Mosquitoes were collected from 50 originally randomly
selected households in Kirare using Centre for Disease
Control light traps (John W. Hock Company, Gainesville,
USA) hung beside an occupied bed with an untreated bed
net. Mosquitoes were collected from each of the selected
households once weekly (10 houses sampled on the night
of each weekday), as described [16,18]. Traps were switched
on at 18:00 hours and off at 06:00 hours by trained field
assistants. Caught mosquitoes were transferred to paper
cups and transported to the laboratory in Tanga for identi-
fication using morphological criteria. The live female
vectors (An. gambiae, An. funestus and Cx. quinquefasciatus)
were dissected under microscope for larvae of W. bancrofti,
as described before [13].
Questionnaire surveys for treatment coverage and bed
net use
Questionnaire surveys were carried out in the study
communities and study schools in Tanga District shortly
after each MDA to assess the treatment coverage. In
these surveys, individuals were asked in privacy whether
or not they had taken the drugs (in communities, parents
answered on behalf of their children below 15 years of
age). In November 2013, a more elaborate questionnaire
survey was carried out among individuals identified to be
mf positive during community survey 9, to assess their
views and adherence with the MDA programme.
Very few households possessed bed nets at the start of
the study in 2003, but bed nets were observed to gradually
become more common during the study. In September
2011, insecticide treated nets (ITNs) were moreover
distributed to every household in Tanga Region [18].
During the latter community post-MDA questionnaire
surveys, heads of households were therefore also asked
about the number and type of bed nets possessed in their
household (checked by visual inspection when inhabitants
allowed). During the post MDA 7 survey in January 2012,
97.6% of 380 households indicated they possessed at least
one bed net (96.6% an ITN), and during the post MDA 8
survey in February 2013, 81.1% of 392 households
possessed at least one net (70.7% an ITN).
Mapping
Longitude and latitude geo-coordinates of study sites
were recorded with a hand held GPS (eTrex, Garmin).
Table 1 Overview of the LF status in Kirare, as seen
during the pre-MDA survey in September 2004
Characteristic
Registered population (≥10 years) 336
Microfilaraemia (≥10 years)
Prevalence 33.6%
GMIa among examined 8.8
GMIa among positive 881
CFAb prevalence (≥10 years)c 63.3%
Bm14 prevalence (≥10 years)c 85.7%
Hydrocele prevalence in males (≥15 years)d 42.7%
Elephantiasis prevalence in all (≥15 years)d 5.2%
Based on data from Mtambuuni and Mashine hamlets.
aGeometric mean intensity, in mf/ml blood.
bCirculating filarial antigens.
cAssessed in volunteers from mosquito collection houses (n =49).
dAssessed in 117 males (hydrocele) and 269 males and females
(elephantiasis), respectively.
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Region were prepared in the open source geographical
information system Qgis (version 2.0). To obtain an
indication of prevalence zones beyond the individual
sampling locations, kriging, which quantifies unknown
values from known values based on their respective
distance and direction, was considered for the school
spot check CFA data. Data trends and distribution was first
explored using ArcGIS 10.1 Geostatistical Analyst (ESRI,
Redlands, CA) to ensure the most accurate geostatistical
interpolation method was applied. Empirical Bayesian
kriging was chosen as the favored interpolation method,
as it is considered more accurate than ordinary kriging for
small datasets and due to its ability to account for the
error introduced by estimating the underlying variogram
[20]. Parameters were slightly adjusted to give the best
model fit to the empirical data (standardized mean
nearest to zero, smallest root-mean-square prediction
error, average standard error nearest the rootmean-square
prediction error, and standardized root-mean-square
prediction error nearest to one).
Data analysis
Although community surveys in Tanga District also
included younger individuals, only those aged ≥10 years
and ≥15 years were included in analysis of LF infection
and LF chronic disease, respectively, in order to allow easy
comparison of findings to those from community surveys
in the other districts (only little infection and chronic
disease is seen in individuals below these age groups).
The mf intensities were adjusted for sampling time by
multiplying the counts with a time-specific factor, as pre-
viously described [21]. Geometric mean intensities (GMIs)
of mf counts were calculated as antilog [(Σ log x +1)/n] – 1,
with x being the mf/ml and n the number of individuals
included. During Tanga District community surveys 7–9,
and during the community spot check surveys in the other
districts of Tanga Region in 2013, when only CFA positive
individuals were examined for mf, the community mf preva-
lence was calculated as: (b/a) * (d/c) * 100, where a = number
of individuals in the community examined for CFA,
b = number of those examined for CFA being positive,
c = number of CFA positives examined for mf, and
d = number of those examined for mf being positive
[18]. In these surveys, the community mf GMI was
calculated as antilog [(Σlog x +1)/(c/b) * a] – 1, with x being
the mf/ml blood and (c/b) * a being the number of individ-
uals examined (taking into account that sometimes not all
CFA positive individuals were examined for mf).
Entomological indices for vector biting and transmission
were calculated as described previously [13]. Briefly, the
monthly biting rate (MBR, a measure of the number of
mosquito bites per person in the month) was calculated
as: (total mosquito catch * days in month * 3) / (number ofcatching nights * number of light traps * 2). The monthly
transmission potential (MTP, a measure of the number of
infective larvae to which a person is exposed in the month)
was calculated as: (MBR * total number of infective larvae
seen in the dissections) / (number of mosquitoes dissected).
Categorical variables were compared statistically by
chi-square test, whereas continuous variables were
compared by t-test or one-way analysis of variance, as
appropriate. P-values less than 0.05 were considered
statistically significant.
Results
Tanga District communities
Results from the pre-MDA survey in Kirare village in
2004 are summarized in Table 1. High levels of LF
infection and chronic disease were recorded, with
63.3% and 33.6% of individuals aged ≥10 years being
positive for CFA and mf, respectively, 42.7% of males
aged ≥15 years having hydrocele and 5.2% of individuals
aged ≥15 years having elephantiasis.
The LF infection results from surveys 7, 8 and 9 in
Kirare, Kiomoni and Kisimatui villages are shown in
Table 2, and these results are compared to those from
Kirare in 2004 in Figure 2. Both CFA and mf prevalences
were considerably lower in the later surveys than in
Kirare in 2004, and on average for the three villages
reached 15.5% and 3.5%, respectively during survey 9
(decrease by 75.5% and 89.6%, respectively, compared
to the baseline level in Kirare). The decrease in CFA
prevalence between survey 7 and 9 was statistically
significant in all three villages, and for the villages com-
bined it was highly significant between each individual
survey (p =0.009 between survey 7 and 8; p <0.001 between
survey 8 and 9). The decrease in mf prevalence and mf
GMI among all examined between survey 7 and 9 was also
Table 2 Circulating filarial antigens and microfilariae in the rural study communities in Tanga District
Communitya Time (number)
of survey
Survey
population
Circulating filarial antigen Microfilariae
No. examined No. positive (%) p-valueb No. examinedc No. positive Community
mf prevalencec
Mf GMId for
all examined
Mf GMI for
positives
Kirare Nov-10 (7) 554 319 98 (30.7)
0.051
89 15 5.2 0.31 178.9
Nov-11 (8) 554 311 74 (23.8) 60 9 3.6 0.20 180.8
Sep-13 (9) 624 422 69 (16.4)
0.012
60 20 5.5 0.31 293.7
Kiomoni Nov-10 (7) 394 293 71 (24.2)
0.323
68 17 6.1 0.44 423.1
Nov-11 (8) 394 233 48 (20.6) 48 7 3.0 0.20 487.3
Sep-13 (9) 451 338 42 (12.4)
0.008
36 5 1.7 0.10 282.2
Kisimatui Nov-10 (7) 492 277 107 (38.6)
0.075
91 27 11.5 0.80 171.7
Nov-11 (8) 492 259 81 (31.3) 61 17 8.7 0.46 74.5
Sep-13 (9) 517 301 53 (17.6)
<0.001
42 6 2.5 0.13 107.7
All three combined Nov-10 (7) 1440 889 276 (31.0)
0.009
248 59 7.4 0.49 225.0
Nov-11 (8) 1440 803 203 (25.3) 169 33 4.9 0.28 141.6
Sep-13 (9) 1592 1061 164 (15.5)
<0.001
138 31e 3.5 0.21 240.4
Results are from individuals aged ≥10 years during surveys 7, 8 and 9. Results from earlier surveys were given in [18].
aTwo hamlets of Kirare (Mtambuuni, Mashine), one hamlet of Kiomoni (Mabavu) and one hamlet of Kisimatui (Majengo).
bFor difference in prevalence (Pearson chi-square test).
cOnly CFA positives were examined. See Methods for calculation.
dGeometric mean intensity, in mf/ml blood. See Methods for calculation.
eEight females, 23 males (mean age: 37.1 years; range 10–73 years).
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Figure 2 Prevalence of circulating filarial antigens (A) and microfilaraemia (B) in the rural study communities in Tanga District during
surveys 1 and 7–9. Data are from individuals aged ≥10 years from two hamlets of Kirare (Mtambuuni, Mashine), one hamlet of Kiomoni
(Mabavu) and one hamlet of Kisimatui (Majengo). Bar = prevalence in Kirare at the pre-MDA survey in 2004; Orange line = prevalence in Kirare in
survey 7–9; Green line = prevalence in Kiomoni in survey 7–9; Blue line = prevalence in Kisimatui in survey 7–9. In the pre-MDA survey all individuals
were examined for mf, and volunteers from mosquito collection houses only were examined for CFA by ELISA. In surveys 7–9 all individuals were first
examined for CFA with ICT cards, and those positive were examined for mf. Vertical stippled lines indicate rounds of MDA.
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increase was noted in Kirare between survey 8 and 9 (statis-
tics cannot be computed due to the method of assessing
these indices, see Methods).
The chronic LF morbidity results from survey 9 (2013)
are compared to those from the pre-MDA survey in Kirare
(2004) in Table 3. It is remarkable that the prevalence of
chronic signs for both hydrocele and elephantiasis in 2013
was less than half of that in 2004. For hydrocele, this de-
crease in prevalence was highly significant, both when
comparing Kirare in 2004 to Kirare in 2013 and when
comparing Kirare in 2004 to all three villages combined in
2013 (p <0.001 for both tests). For elephantiasis, the de-
crease was only significant for the second but not for
the first of these comparisons (p =0.004 and p =0.11,respectively), most likely because of the low numbers of
cases in the former. It is noteworthy in this respect that
the mean age of those with hydrocele and elephantiasis did
not differ significantly between 2004 and 2013 (p >0.05 for
all tests).
Results from the two months of vector and transmis-
sion surveillance in the post-MDA 7 and post MDA 8
periods are shown in Table 4, together with findings
from the full-time pre-MDA and post-MDA 6 periods.
When comparing results, it should be noted that not
only the length of collection period differed, but also
that the post-MDA 7 and 8 collections were made to-
wards the end of the long rainy season when peak mos-
quito density was expected. The post-MDA 7 period
thus had exceptionally low vector mosquito density,
Table 3 Chronic LF morbidity in the rural study communities in Tanga District
Survey number (year)
and communitya
Hydrocele (males only) Elephantiasis (females and males)
No. examined No. positive (%) p-valueb Mean age (range)
of positives
p-valuec No. examined No. positive (%) p-valuea Mean age (range)
of positives
p-valueb
Survey 1 (2004)
Kirare 117 50 (42.7) - 50.2 (16–76) - 269 14 (5.2) - 51.1 (26–74) -
Survey 9 (2013)
Kirare 123 22 (17.9) < 0.001 53.7 (16–90) 0.43 334 8 (2.4) 0.11 54.9 (41–84) 0.58
All 3 communities 304 44 (14.5) < 0.001 53.8 (16–90) 0.31 808 14 (1.7) 0.004 54.9 (36–85) 0.52
Results are from individuals aged ≥15 years examined during the pre-MDA survey (2004) and after 8 rounds of MDA (2013).
aTwo hamlets of Kirare (Mtambuuni, Mashine), one hamlet of Kiomoni (Mabavu) and one hamlet of Kisimatui (Majengo).
bPearson chi-square test comparing prevalence in 2004 to prevalences in 2013.
ct-test comparing mean age in 2004 to mean ages in 2013.
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Table 4 Vector mosquito catches from the 50 collection houses in Kirare, and the outcome of dissections
Period Months of
collection
No. collected
(mean per month)
Mean monthly
biting rate
No.
dissected
No. infecteda
(% of dissected)
No. infectiveb
(% of dissected)
Mean monthly
transmission
potential
Pre-MDA (Nov-03 to
Sep-04)
11
An. gambiae 2335 (212.3) 49.39 1477 56 (3.8) 20 (1.35) 1.90
An funestus 3385 (207.7) 71.3 2080 94 (4.5) 48 (2.31) 3.47
Cx. quinquefasciatus 2626 (238.7) 53.7 1839 37 (2.0) 9 (0.49) 0.69
Total 8346 (758.7) 174.3 5396 187 (3.5) 11 (1.43) 6.08
Post-MDA 6 (Dec-10 to
Nov-11)
12
An. gambiae 416 (34.7) 7.3 387 0 (0.0) 0 (0.0) 0.00
An funestus 74 (6.2) 1.4 74 0 (0.0) 0 (0.0) 0.00
Cx. quinquefasciatus 8492 (707.7) 153.9 7252 2 (0.03) 1 (0.01) 0.05
Total 8982 (748.5) 161.8 7713 2 (0.03) 1 (0.01) 0.05
Post-MDA 7c 2
An. gambiae 24 (12.0) 5.2 19 0 0 -
An funestus 26 (13.0) 5.7 8 0 0 -
Cx. quinquefasciatus 104 (52.0) 22.7 98 0 0 -
Total 154 (77.0) 33.6 125 0 0 -
Post-MDA 8d 2
An. gambiae 246 (123.0) 53.6 226 0 0 -
An funestus 0 (0.0) 0.0 0 0 0 -
Cx. quinquefasciatus 1454 (727.0) 316.8 1306 0 0 -
Total 1700 (850.0) 370.4 1532 0 0 -
Mosquitoes were collected in all four hamlets of Kirare. Results shown are from the full pre-MDA and post-MDA 6 periods as well as from two months of collection
during the peak mosquito seasons in 2012 and 2013. Results from the post-MDA 1–5 periods were given in [16,18].
aWith any larval stage (L1, L2, L3) of W. bancrofti; bWith L3 larval stage of W. bancrofti.
cJune/July, 2012 (42 sampling nights; 420 trap nights); dMay/June, 2013 (42 sampling nights; 420 trap nights).
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period. The previously reported [16,18] shift in vector
composition from being predominantly anophelines
during the pre-MDA period to being predominantly
Culex quinquefasciatus in the later part of the study
was still clearly seen. None of the dissected vector
mosquitoes from post-MDA periods 7 or 8 were found to
carry filarial infections. The mean MTP for the four
main transmission months of May-August for the
years 2004 to 2013 is shown in Figure 3 (only 2 months
included for 2012 and 2013; see Methods) and indicates
a dramatic decrease in transmission during the study
period.
The surveyed treatment coverages for MDA 7 and 8 in
Tanga District were generally on the lower side. Thus, at
the post-MDA 7 questionnaire survey in January 2012,
55.9% of 1432 interviewed community members ≥5 years
indicated they had taken the drugs. At the post-MDA 8
questionnaire survey in February 2013, 50.5% of 1399
interviewed community members ≥5 years indicated
they had taken the drugs. The reported treatmentcoverages from the programme for the entire Tanga
District at these two MDAs were 51% and 46%,
respectively.
Results from the questionnaire survey among the 32
mf positive individuals identified during survey 9 are
shown in Table 5. A total of 29 individuals participated,
of which most (86.2%) indicated they had stayed more
than 5 years in the village. The great majority (89.7%)
indicated they knew about the MDA programme and
82.8% expressed the opinion that it was important that
everyone in the community should take the tablets.
However, 23 (79.3%) admitted that they did not take the
tablets last time because they were absent (13), tablets
were not distributed (5), they were not informed
about the distribution (3), they did not like the tablets
(1) or they feared for side effects (1). Thus, 21 (91.3%
of those who did not take the tablets) indicated that
they had not been offered the tablets during last
MDA, as an explanation for their non-compliance. All
indicated they would take the tablets during next
MDA round.
Figure 3 Mean monthly transmission potential (MTP) for the main transmission months of May-August for the years of 2004–2013.
Only 2 months included for 2012 and 2013 (see Methods).
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The new intakes of Standard 1 pupils from the 10 study
schools were examined for CFA shortly after starting
school. The results from surveys 7, 8 and 9 are shown in
Table 6, and these results are compared to those from 2004
in Figure 4. The average CFA prevalence for the 10 schools
combined decreased progressively from year to year, and
reached 2.3% during survey 9 (from a pre-MDA prevalence
of 25.2%; decrease by 90.9%). The decrease in CFA
prevalence between survey 7 and 8 was not statistically
significant (p =0.65), whereas between survey 8 and 9 it
was highly significant (p <0.001). Similar trends were seen
in the four school clusters although with some fluctuations
due to the low number of CFA positive pupils.
The post-MDA questionnaires among Standard 1
pupils in the 10 schools indicated that only 18.8% had
taken the treatment in MDA 7 (among 845 pupils
interviewed in January 2012) whereas 44.9% had taken the
treatment in MDA 8 (among 770 pupils interviewed in
February 2013).
Other districts of Tanga Region
Results from the spot check surveys for CFA in the 16
schools in the other 7 districts of Tanga Region are shown
in Table 7. CFA prevalences were low in the inland
districts of Handeni, Kilindi, and Lushoto (average of 0.5%
for the 1204 examined pupils at the 6 sites), intermediate
in Korogwe and Muheza (average of 1.8% for the 1004
examined pupils at the 5 sites) and highest in the coastal
districts of Mkinga and Pangani (average of 5.5% for the
998 pupils examined at the 5 sites), and the difference in
prevalence between these three groups was statistically
significant (p <0.001). Highest CFA prevalence (11.0%)
was recorded in Mkalamo School in Pangani District.
The difference in pattern of CFA prevalence in
schoolchildren between inland and coastal sites is alsoobvious from Figure 5A (in which results from the 4
school clusters in Tanga District have also been in-
cluded). Kriging on the empirical data from the 16
schools plus the four school clusters in Tanga district
was used to prepare and show CFA-prevalence iso-lines
on the regional map (Figure 5B). The map indicates
that all of Kilindi and Lushoto districts and most of
Korogwe District are located on the lower site of the
2% CFA-prevalence iso-line.
Results from the spot check surveys in the 9 communities
in the other 7 districts of Tanga Region are shown in
Table 8. As expected, the community CFA prevalences
were higher than those of the schoolchildren, but a
similar pattern was seen. The most inland districts of
Handeni, Kilindi and Lushoto had the lowest prevalences
(average of 1.1% for the 560 individuals at the 3 sites),
Korogwe and Muheza districts had intermediate preva-
lences (average of 7.2% for the 609 individuals at the 3
sites), and the coastal districts of Mkinga and Pangani
had highest prevalences (average of 20.0% for the 596
individuals tested). The difference in prevalence between
the three groups was statistically significant (p <0.001).
Microfilariae were only detected in the districts with the
highest CFA prevalences (Pangani, Mkinga, Korogwe).
These patterns are also obvious from Figure 6, in
which results from the three study communities in
Tanga District have also been included.
The findings from clinical examination of community
members reflected the LF infection patterns. Thus, the
prevalence of hydrocele was significantly higher in
coastal Pangani and Mkinga districts (10.2% for 332
examined males) than in the more inland Handeni,
Kilindi, Lushoto, Korogwe and Muheza districts (3.1% for
522 examined males; p <0.001), and the prevalence of
elephantiasis was significantly higher in the first two
districts (3.8% for 494 examined individuals) than in
Table 5 Questionnaire-based assessment of microfilaria
positive individuals in the three rural study communities
in Tanga District
No. responses
(%)
How long time have you lived in this village (n =29)?
1-5 years 3 (10.3)
> 5 years 25 (86.2)
No answer 1 (3.4)
Have you heard about the MDA programme (n =29)?
Yes 26 (89.7)
No 3 (10.3)
Did you take the MDA tablets in February 2013 (n =29)?
Yes 4 (13.8)
No 23 (79.3)
Don’t know 2 (6.9)
Why did you not take the tablets (n =23)?
Was absent 13 (56.5)
Tablets not distributed 5 (21.7)
Not informed 3 (13.0)
Not like the tablets 1 (4.3)
Fear of side effects 1 (4.3)
Did you take the tablets during previous MDAs (n =29)?
No 9 (31.0)
Yes, once 6 (20.7)
Yes, twice 8 (27.6)
Yes, more than twice 5 (17.2)
Don’t know 1 (3.4)
Why not (n =9)?
Was absent 7 (77.8)
Tablets not distributed 1 (11.1)
Fear of side effects 1 (11.1)
Will you take the tablets during next MDA (n =29)?
Yes 29 (100.0)
Why will you take the tablets during next MDA (n =29)?
To protect me from getting LF 22 (75.9)
To prevent spread of LF in the village 5 (17.2)
Instructed by village leaders 1 (3.4)
Because many people take them 1 (3.4)
29 of the 31 individuals found mf positive during survey 9 (September 2013)
in Kirare, Kiomoni and Kisimatui were interviewed (7 females, 22 males; mean
age 39.4 years; age range 8–73 years).
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p <0.001).
Discussion
Since launching of the LF control programme in Tanga
Region in 2004, the present project has monitored theeffect of MDA on LF infection and transmission in rural
areas of Tanga District through repeated human cross
sectional surveys in communities and schools and
continuous vector and transmission surveillance [16-18].
As infection and transmission indices had reached rela-
tively low levels, and for logistical reasons, most activities
were suspended in 2012. In 2013, the same study commu-
nities and schools in Tanga District were re-examined. In
addition, it was decided in 2013 to carry out spot check
surveys in communities and schools in the other 7
districts of Tanga Region, to assess the overall regional LF
status after 8 rounds of MDA.
In the longitudinal study in Tanga District, the human
infection burden continued to decrease from one survey
to the next. After 8 rounds of MDA in 2013, the CFA
and mf prevalences in the combined study communities
were reduced by 75.5% and 89.6%, respectively, compared
to the baseline level in Kirare, and in the 10 study schools,
the CFA prevalence on average was reduced by 90.9%
compared to baseline. Continued decrease in these indices
was also obvious in the later part of the study in both
communities and schools, although it was less evident
between survey 7 and 8 (where only one MDA was
administered) than between survey 8 and 9 (where 2
MDAs were administered). The mf GMI among the
examined individuals in the three communities was
reduced even more (by 97.6% compared to baseline
in Kirare), thus indicating a considerable reduction in
number of mf being available for onward transmission
by vector mosquitoes. On the other hand, the mf
GMI among individuals who were still mf positive
remained very high, suggesting that some of these
more systematically had missed the annual MDAs
(systematic non-compliers) and served as important
sources of mf for continued transmission.
Two issues are important to consider when evaluating
this positive reduction in community and school LF
infection burdens. First, the prevalence levels for both mf
and CFA in 2013 were still well above those recommended
for stopping MDA (1% and 2%, respectively) [5,22]. Second,
although there can be little doubt that the major cause of
the decrease was the MDAs, other factors contributed.
Bed nets were rarely used in the beginning of the
study in 2004 [16] but gradually became more com-
mon, and ITNs were distributed free of charge to all
households in Tanga Region in 2011. Moreover, there
has been a major change in vector mosquito density
and species composition during the period of the
study, as previously reported in detail [16,18,23], with
a considerable decline in density of the important
Anopheles gambiae and An. funestus vectors, and with
the few remaining An. gambiae mainly being of the
less anthropophilic An. arabiensis sibling species [24].
It is still unclear what exactly has caused this change,
Table 6 Circulating filarial antigen (CFA) in Standard 1 pupils from 10 rural primary schools in Tanga District
Time (number)
of survey
No. pupils
registered
No. examined
(% of registered)
No. girls/boys
(ratio)a
Mean age in years
(range)a
No. positive for CFA
(% of examined)
p-value for change in CFA
prevalence from previous yearb
Nov-10 (7) 966 831 (86.0) 404/427 (0.95) 7.5 (6–12) 51 (6.1) 0.80
Dec-11 (8) 943 889 (94.3) 421/468 (0.92) 7.5 (6–11) 50 (5.6) 0.65
Sep-13 (9) 1124 990 (88.1) 492/488 (1.01) 7.6 (6–12) 23 (2.3) < 0.001
Each year, the new intake of Standard 1 pupils in the 10 schools (Kiomoni, Mafuriko, Marungu, Kirare, Mapojoni, Pongwe, Kigandini, Maweni, Ziwani and Kange)
was examined. Results from earlier surveys were given in [17,18].
aFor examined pupils.
bPearsons chi-square test.
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as the increased use of ITNs, have undoubtedly played
important roles.
Other studies have assessed the effect of MDA on LF
infection, especially in areas where control programmes
have used the DEC/albendazole combination (e.g. [25-29]).
DEC cannot be used for MDA in most countries of
sub-Saharan Africa, because of the risk of severe adverse
reactions in individuals with concomitant O. volvulus
infection, and is substituted by ivermectin in these
areas. Successful elimination of LF with the ivermectin/
albendazole combination was recently reported from
Togo, which however had very low pre-MDA LF endem-
icity level [30,31]. Programmes in Sierre Leone [32] and
Nigeria [33,34], partly building on existing and effective
Community Directed Intervention programmes for
control of onchocerciasis, and with low to moderate
pre-MDA levels of LF endemicity and remarkably high
treatment coverages, have also shown good progress
with this combination. The LF elimination programme in
Zanzibar similarly reported a marked drop in microfilarae-
mia after five rounds of ivermectin/albendazole MDA withFigure 4 Prevalence of circulating filarial antigens in Standard 1 pupi
1 and 7–9. Bar = prevalence in all 10 schools combined at the pre-MDA surv
surveys 7–9. Thin stippled lines = prevalence in school clusters according
no. 1–3), north (Kiomoni and Mafuriko schools; no. 4–5), close west (Maweni a
and Ziwani schools; no. 8–10) of Tanga city during survey 7–9. Vertical stippleintensive community mobilization and high treatment cov-
erages [35]. The combination of very high LF endemicity at
baseline and moderate treatment coverages is probably an
important reason for the relatively high human infection
level observed after 8 rounds of MDA in the coastal areas
in the present study.
The aim of MDAs is to reduce the mf load in the human
population to prevent infection of vectors and thereby
ultimately to interrupt transmission [4,5]. The sharp decline
observed in transmission in Kirare after the first MDAs,
should most likely primarily be attributed to the effect of
the treatment, but – as mentioned earlier - increased bed
net use and changes in the vector population also played a
role. The fact that no infective vector mosquitoes were
detected after MDA 7 does not necessarily mean that
transmission had been completely interrupted, − only
that not enough mosquitoes were caught and examined for
infective larvae. This is a major challenge in LF transmission
surveillance, that trapping of enormous numbers of mosqui-
toes is necessary to detect infective ones when transmission
level is low [36]. The recent increase in importance of Culex
quinquefasciatus as LF vectors in the study area suggest thatls from 10 rural primary schools in Tanga District during surveys
ey in 2004. Thick line = prevalence for all 10 schools combined during
to their location to the south (Kirare, Mapojoni and Marungu schools;
nd Kange schools; no. 6–7) and more distant west (Pongwe, Kigandini
d lines indicate rounds of MDA.
Table 7 School surveys for circulating filarial antigen in the other seven districts of Tanga Region
District School Classes included No. examined Mean age in years (range) Female: male ratio No. positive (%)
Handeni (1) Madebe 1-6 200 9.9 (7–16) 1.1 1 (0.5)
Komkonga 1-2 199 8.2 (7–11) 1.4 2 (1.0)
Kilindi (2) Songe 1-2 202 7.8 (6–12) 1.5 0 (0.0)
Lukole/Negero 1-6 202 10.0 (6–16) 1.3 3 (1.5)
Korogwe (3) Kwamndolwa 1-3 203 8.5 (7–11) 1.3 4 (2.0)
Vuluni 1-6 200 10.2 (6–15) 1.1 1 (0.5)
Mkalamo 1-7 200 9.9 (7–14) 1.2 2 (1.0)
Lushoto (4) Mwangoi 1-3 200 9.2 (6–14) 1.2 0 (0.0)
Mnazi 1-3 201 9.6 (6–15) 1.2 0 (0.0)
Mkinga (5) Kwale 1-6 199 9.6 (7–15) 1.3 19 (9.5)
Gombero 1-6 200 9.9 (5–15) 1.0 6 (3.0)
Mwakijembe 1-3 202 9.3 (7–14) 1.2 1 (0.5)
Muheza (6) Mkuzi 1-3 200 9.7 (7–13) 1.0 3 (1.5)
Mamboleo 1-3 201 9.6 (6–14) 1.0 8 (4.0)
Pangani (7) Kipumbwi 1-2 197 7.8 (7–12) 1.0 7 (3.6)
Mkalamo 1-3 200 8.4 (7–14) 1.0 22 (11.0)
Total - - 3206 9.2 (5–16) 1.2 79 (2.5)
Examinations started with Standard 1 pupils and thereafter continued progressively to higher classes until the required number had been examined.
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with this species, might be a better option for entomological
assessment of LF transmission in the future.
The marked reduction in chronic LF morbidity burden
observed in the longitudinal community study, with
prevalence of hydrocele and elephantiasis after 8 rounds
of MDA being less than half of what it was at baseline,
was unexpected. A positive effect of MDAs with the
ivermectin/albendazole combination on lymphedema size
was previously also reported from the Tanzanian NLFEP
[7]. A number of possible explanations can be suggested,
which alone or in combination may have contributed
to this. First, the lowered transmission intensity and/or
infection burden with increasing number of MDAs may
have reduced or delayed development of new cases.
Secondly, there could have been a direct, perhaps
anti-inflammatory, effect of treatment on the chronic
morbidity, although evidence for such properties of
ivermectin or albendazole is meagre [38]. Thirdly, surgical
removal of hydroceles, although not commonly performed
in the area due to high cost and limited hospital capacity,
may have reduced the number of hydroceles. Fourthly,
better hygiene due to general improved standard of living
(better availability of e.g. water, soap, shoes and antibiotics)
may have contributed to reduce the frequency of superficial
secondary bacterial/fungal infections which often trigger
and aggravate lymphedema and elephantiasis formation
[2,38]. Lastly, a number of incidents during field work sug-
gested that some individuals with chronic morbidity
in the later part of the study hid themselves to avoidexamination, as previous examinations had not pro-
vided alleviation of their disease symptoms. Several
cross-sectional follow-up studies in the past have suggested
that DEC might have a positive effect on lymphedema and
hydrocele, but cohort studies following individual patients
over a period of time have not been able to confirm
this [39,40].
During MDA 7 and 8, the reported treatment coverages
for Tanga District as well as the surveyed treatment cover-
ages in the study communities and schools were on the
lower side. With a range of 46-56%, these were markedly
lower than the minimum of 65% required for reaching LF
transmission interruption within reasonable time [5].
Treatment coverages moreover appeared to have declined
when compared with previous years [16,18]. To attain and
maintain high treatment coverage has been a commonly
reported challenge for LF control programmes, both in
Tanzania [41] and elsewhere [42]. The relatively high mf
GMI among individuals who were still mf positive
suggested that many of these had been poorly covered by
the MDAs. This was confirmed in the interviews with the
mf positive individuals, which moreover indicated that
major reasons for not being treated were: 1) individuals
had been away during distribution; 2) the tablets had not
been distributed; or 3) individuals had not been informed
about the distribution. Similar findings were reported
from a recent larger study on MDA drug uptake in other
parts of Tanzania, which concluded that although some
people for various reasons refuse to take the tablets, com-
pliance depended more on provider related factors than
Figure 5 Map of Tanga Region showing circulating filarial antigen (CFA) prevalence in primary school children in 2013. A =measured
prevalence levels at the survey sites. B= Prevalence isolines prepared by Bayesian kriging on the empirical data. Numbers indicate districts: 1 = Handeni,
2 = Kilindi, 3 = Korogwe, 4 = Lushoto, 5 =Mkinga, 6 =Muheza, 7 = Pangani, 8 = Tanga.
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study also indicated that bed nets gradually gained
more popularity in the populations during the period.
A particularly marked increase in bed net coveragewas - not surprisingly - observed immediately after the
free distribution of ITNs in 2011. However, this rapidly
dropped to more moderate level the following year, when
it was also commonly observed in the surroundings that
Table 8 Community surveys for LF infection in the other seven districts of Tanga Region
District Village Circulating filarial antigen Microfilarae
No. examined Mean age in
years (range)
Female:
male ratio
No. positive (%) No. examineda No. positive Community mf
prevalence in %b
Handeni (1) Madebe 181 30.7 (10–80) 0.8 4 (2.2) 2 0 0.0
Kilindi (2) Songe 180 23.8 (10–100) 0.5 0 (0.0) 0 0 0.0
Korogwe (3) Kwamdolwa 207 40.2 (10–86) 1.2 16 (7.7) 15 2 1.0
Korogwe (3) Mkalamo 222 35.1 (15–94) 0.6 22 (9.9) 17 4 2.3
Lushoto (4) Mwangoi 199 34.9 (10–90) 1.1 2 (1.0) 2 0 0.0
Mkinga (5) Kwale 202 37.0 (10–100) 0.8 36 (17.8) 32 8 4.5
Mkinga (5) Mwakijembe 200 42.5 (16–100) 0.6 35 (17.5) 23 4 3.0
Muheza (6) Mkuzi 180 27.2 (10–84) 0.9 6 (3.3) 2 0 0.0
Pangani (7) Kipumbwi 194 27.4 (10–90) 0.4 48 (24.7) 27 6 5.5
Total - 1765 33.5 (10–100) 0.7 169 (9.6) 120 24c 1.9
Volunteers aged ≥10 years were examined.
aOnly CFA positives were examined.
bSee Methods for calculation.
cFive females, 19 males (mean age: 34.8 years; range 11–70 years); GMI =179.5 mf/ml blood.
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human beds (like protection of chicken, seedlings and
tomato plants, for fishing, and for collection of plastic
bottles for recycling). Possibly some of these nets had
been damaged and therefore could no longer serve
their original purpose.
The spot-check surveys in 2013 showed considerable
differences in LF infection and disease burden between
the different parts of Tanga Region. Highest prevalences
of CFA and mf were seen in the coastal areas, whereas
there were lower prevalences in the more inland areas
and particularly little infection in the highlands in the
north-western and south-western parts of the region.
A similar pattern, although with much higher prevalences,
was reported in the 1950’s by Jordan [43]. It is likely that
this distinct pattern largely is shaped by environmental con-
ditions affecting the vectors, such as altitude, temperature,
rainfall and humidity. Baseline data had originally been
collected by the NLFEP from various sites in Tanga
Region, but these unfortunately had irregularities that
made them of little value for comparison to the data from
the present study. The three MDAs with ivermectin
applied for onchocerciasis control in highland areas of the
Usambara Mountains before start of the LF control may
potentially also have had an impact on LF infection
in co-endemicity areas, as reported from elsewhere
[44,45]. When compared to the rest of the coastal
area, Tanga District was noted to have particularly
low CFA prevalences in schoolchildren. It is tempting
to speculate that control activities had been more intense
near Tanga city, which accommodates the regional
headquarters for the LF control programme, than in the
districts to the North (Mkinga) and South (Pangani),
although this was not immediately reflected in thereported district treatment coverages. A recent study on
urban LF in Tanga city also indicated that a considerable
decrease in transmission had occurred in recent years
[46]. The spot check data from the present study will be a
useful reference for future assessment of regional progress
in LF control. They moreover provide a background for
considering a face-out of MDA activities in the two
districts with little LF (Lushoto and Kilindi) by following
WHO guidelines [5,22], which could perhaps also release
resources for more concentrated control efforts in the
more affected districts.
Overall, the study showed that LF still is widespread in
many parts of Tanga Region after 8 rounds of MDA, in
particular in the coastal areas. This calls for intensified
control, to effectively eliminate transmission. In this
respect, some lessons learned from the present study
might be useful. First, the MDA activity needs to be
strengthened to ensure higher treatment coverage. This
includes raising the population’s awareness of LF and
interest in the MDA activity, and not least to ensure that
all those who are already convinced and prepared to
participate in the treatment campaigns also get the
opportunity [15,41]. This will probably mean that more
time has to be spent on the drug distribution activity
and on informing and engaging the populations, but the
alternative will be that treatment coverage remains too
low. More frequent treatment (e.g. half yearly) could also
be considered for the high endemicity areas, and perhaps
even the use of DEC/albendazole instead of the ivermectin/
albendazole combination, now that O. volvulus transmis-
sion has been brought close to elimination in the previous
onchocerciasis endemic highland areas. In respect to the
latter option it is noteworthy that DEC/albendazole is used
for LF control in the nearby coastal districts of Kenya [47].
Figure 6 Map of Tanga Region showing community prevalence of circulating filarial antigens (A) and microfilariaemia (B) in 2013. Volunteers
aged ≥10 years were first examined for circulating filarial antigens (CFA) with ICT cards and those positive were examined for microfilariae (Mf).
Simonsen et al. Parasites & Vectors 2014, 7:507 Page 16 of 19
http://www.parasitesandvectors.com/content/7/1/507Second, there is a need for further advocacy to strengthen
bed net usage. There has been increasing use of bed nets in
the area during the past decade. However, the very highbed net coverage noted in 2011 was somehow inflated, due
to the free household distribution of ITNs, and it declined
to some extent afterwards. Bed net use can be an important
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necessary to invest efforts in motivating and engaging
people in correct usage of the nets to give optimal
health benefits. Otherwise many nets will be transformed
into other useful appliances during the seasons with low
mosquito densities. Third, there should be more attention
to the fact that males are the main LF infection carriers
and sufferers, especially after initiation of control. In the
present 2013 surveys, 74.5% and 79.2% of the remaining
mf positive individuals in Tanga District and in the
other districts of the region, respectively, were males
(thus contributing most to transmission), and 87.9%
and 84.7% of those with chronic LF disease, respectively,
were males (due to the high frequency of hydrocele). This
could be approached e.g. by having a more deliberate male
focus in LF health messages, by making hydrocelectomies
more accessible for the less wealthy male population, and
by disseminating LF messages not only from health
centres (which are often congested with females and
small children) and during public meetings, but also from
sites where men feel more comfortable and relaxed like
bars, churches and mosques.
Conclusions
The positive downward trend in LF transmission and
human infection previously reported from the highly
endemic Tanga District continued. However, LF was still
widespread in many parts of Tanga Region after 8
rounds of MDA, in particular in the coastal areas to the
north and south of Tanga city. This calls for intensified
control in order to convincingly reach human infection
levels below which transmission can no longer be
maintained. In particular this should include strengthened
efforts to increase the MDA treatment coverage (to at
least ensure that everybody are offered the treatment),
further support to and advocacy for use of bed nets (to
prevent human infection and onward transmission), and
more male focus in health dissemination (as males
are the main reservoir of mf for infection of vectors).
The particular low LF prevalences observed in some
of the inland districts moreover suggest that MDA in
these could be stepped down after rigorous assessment, to
provide more resources for upscale of control activities in
the coastal areas. Monitoring and evaluation should
continue to guide the programme to ensure that the
current major achievements will ultimately lead to
successful LF elimination.
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